Durak Aras, B. Et Al. 2021. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?. Molecular cytogenetics , vol.14, no.1 , 2.

Durak Aras, B., Isik, S., Uskudar Teke, H., Aslan, A., Yavasoglu, F., Gulbas, Z., ... Demirkan, F.(2021). Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?. Molecular cytogenetics , vol.14, no.1, 2.

Durak Aras, BEYHAN Et Al. "Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?," Molecular cytogenetics , vol.14, no.1, 2, 2021

Durak Aras, BEYHAN D. Et Al. "Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?." Molecular cytogenetics , vol.14, no.1, pp.2, 2021

Durak Aras, B. Et Al. (2021) . "Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?." Molecular cytogenetics , vol.14, no.1, p.2.

@article{article, author={BEYHAN DURAK ARAS Et Al. }, title={Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?}, journal={Molecular cytogenetics}, year=2021, pages={2} }